Morbidly Obese Patients with Ileocolic Crohn’s Disease May Benefit from Robotic Surgery

Abstract

Background and Objectives: Obesity is increasing as a comorbid condition for patients requiring surgery for Crohn's disease. Minimally invasive colectomy is ideal for a patient with combined obesity and Crohn's disease. However laparoscopic colon resection is associated with high operative conversion rates in these cases. Data examining the use of robotic surgery in the obese patient with Crohn's disease is sparse.Methods: We examined the feasibility and outcomes of performing a minimally invasive colectomy using the Da Vinci robot in a prospective case series of morbidly obese patients with ileal Crohn's disease.Results: A robotic ileocolectomy was performed in four morbidly obese patients with Crohn's disease. There were no operative conversions or complications with a median length of stay of 3 days. Conclusion:A robotic approach is a promising minimally invasive surgical alternative to laparoscopic surgery for these complex patients.

Influence of Sevoflurane Inhalation Anesthesia on Clinical Outcomes of Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery

“…Obesity is a chronic condition defined as body mass index (BMI) > 30 kg/m 2 , of which morbid obesity, defined as body mass index (BMI) > 40 kg/m 2 , is one of the fastest-growing subgroups [ 1 , 2 ]. In recent years, there has been a gradual increase in the rate of obesity, accompanied by a dramatic increase in obesity-related metabolic diseases, including type 2 diabetes [ 3 , 4 ], and ileal Crohn's disease [ 5 ]. Morbid-obesity-related conditions such as stroke, acute myocardial infarction, hypertension, type 2 diabetes, hyperlipidemia, and obstructive sleep apnea are associated with high mortality rates, with approximately 2.8 million deaths per year among obesity-affected adults [ 6 , 7 ].…”